Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-28
2000-09-26
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 514456, 514651, 514652, 514315, 514220, A61K 3138, A61K 3140, A61K 3135, A61K 31135, A61K 31445
Patent
active
061243469
ABSTRACT:
A method of treating atherosclerosis, independent of lipid lowering, in mammals, including humans, in need of treatment by inhibiting progression of an atherogenic lesion or by stabilizing plaque. Such lesion progression inhibition or plaque stabilization is preferably achieved by directly inhibiting chemokine expression leading to excessive inflammatory cell recruitment by administering certain estrogen agonist/antagonists.
REFERENCES:
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5407955 (1995-04-01), Bryant et al.
patent: 5426123 (1995-06-01), Fontana
patent: 5478847 (1995-12-01), Draper
patent: 5484795 (1996-01-01), Bryant et al.
patent: 5595722 (1997-01-01), Grainger et al.
patent: 5610168 (1997-03-01), Draper
Wiseman, H., et al., Biochem.J. 1993,292, 635-638.
Frazier' Jessen, M. R., et al., Journal of Immunology 1995, 154(4), 1838-1844.
Granier, D. J., et al., Nature Medicine 1995, 1(10), 1067-1073.
Wiseman, H., et al., Cancer Letters 1992, 66, 61-68.
Fuster, V., Circulation 1994, 90(4), 2126-2146.
Wiseman, H., et al., Biochemical Pharmacology 1993, 45(9), 1851-1855.
Schwartz, C. J., et al., Clin. Cardiol. 1991, 14,l-1 --l-16.
Urabe, M., et al. Kyoto-furitsu lka Daigaku Zasshi 1995 104(12), 1535-1544. (Engl. Transl.).
Ross, R., Nature 1993, 362, 801-808.
Kaartinen, M., et al., Circulation 1994, 90(4), 1669-1678.
Benson Gregg C.
Collier Steven W.
Criares Theodore J.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Estrogen agonist/antagonists treatment of atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen agonist/antagonists treatment of atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen agonist/antagonists treatment of atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100719